[Form 4] Verisk Analytics, Inc. Insider Trading Activity

Rhea-AI Filing Summary

ACM Research, Inc. (Ticker: ACMR) – Form 144 filing

An individual named Lisa Yi Lu Feng has filed a notice to sell up to 15,000 common shares of ACM Research, Inc. through Morgan Stanley Smith Barney LLC. The approximate sale date is 07 July 2025. Based on the filing, the shares are valued at an aggregate market price of $420,000, representing roughly 0.023 % of the 63,864,504 shares outstanding. The shares were acquired on the same day through a stock-option exercise paid in cash.

The filer also disclosed a prior sale of 15,000 shares on 24 June 2025 that generated $390,000 in gross proceeds.

• No relationship to the issuer was specified in the form, and no adverse information was cited.
• The filing indicates compliance with Rule 144 and possible 10b5-1 planning, but no plan adoption date is provided.

The transaction is small relative to ACMR’s share count, suggesting limited share-supply impact. However, repeated insider-level sales within a short window may draw investor attention.

Positive

• Transparent Rule 144 compliance ensures public notice of insider-level share disposition.
• Low relative size (0.023 % of shares outstanding) limits market-impact risk.

Negative

• Repeat insider-level sales within a short period could be perceived negatively by some investors.
• No relationship disclosure leaves uncertainty about the seller’s role and potential informational advantage.

Insights

Financial Analyst

TL;DR: Small Rule 144 sale (15k shares, $420k) – neutral impact given <0.1 % float.

The proposed sale equals just 0.023 % of shares outstanding, implying de-minimis dilution or supply effect. Rule 144 filings are routine and signal planned liquidity rather than directional insight. The same seller disposed of an identical amount two weeks earlier, which could indicate personal diversification. No relationship or executive title is listed, so the informational value for forecasting insider sentiment is limited. Overall, I view the filing as not materially impactful to ACMR’s valuation or float dynamics.

Corporate Governance Specialist

TL;DR: Routine compliance disclosure; repeated sales may raise modest governance watch-points.

Rule 144 ensures transparency around restricted-share resales. The filer certifies absence of undisclosed adverse information, meeting governance norms. Yet, two identical sales within three weeks may prompt monitoring for additional planned disposals, especially if the seller holds an influential role that is not clarified here. Lack of 10b5-1 adoption date slightly weakens best-practice optics but does not breach regulation. Materiality remains low.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beckles Kathy Card

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/03/2025		S		326(1)	D	$300.86	9,319	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan entered into by Ms. Card Beckles on March 14, 2024.

	/s/ Thomas C. Wong, Attorney-in-fact	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ACMR shares are proposed for sale under this Form 144?

The filer intends to sell 15,000 common shares of ACM Research.

What is the estimated value of the ACM Research shares to be sold?

The filing cites an aggregate market value of $420,000 for the proposed sale.

When is the planned sale date for the ACMR shares?

The approximate sale date listed is 07 July 2025.

How many ACMR shares were sold by the same person in the past three months?

The filer previously sold 15,000 shares on 24 June 2025 for $390,000.

What percentage of ACMR’s outstanding shares does this sale represent?

About 0.023 % of ACM Research’s 63,864,504 shares outstanding.

Which broker will handle the ACMR share sale?

Morgan Stanley Smith Barney LLC is listed as the broker.